Revvity Inc. (RVTY) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Revvity Inc. (RVTY:NYSE), powered by AI.

Current Price
$101.22
P/E Ratio
48.9
Market Cap
11.8B
Sector
Healthcare
What is the Revvity Inc. stock price forecast?

Revvity Inc. is currently trading at $101.22. View real-time AI analysis on Alpha Lenz.

What is Revvity Inc. insider trading activity?

View the latest insider trading data for Revvity Inc. on Alpha Lenz.

What is Revvity Inc.'s P/E ratio?

Revvity Inc.'s P/E ratio is 48.9.

Revvity Inc.

NYSE · RVTY
$101.22+0.67(+0.67%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Revvity Inc.'s future dividend policy...
Alpha Chat Insight

Revvity Inc. trades at a P/E of 48.9 (premium valuation) with modest ROE of 3.2%.

Ask for details

Company Overview

Revvity Inc. is a prominent company in the healthcare and biological sciences field, offering a comprehensive suite of solutions aimed at improving global health outcomes. The company's core focus lies in delivering innovative products and services that range from diagnostic tools to advanced analytical capabilities for life sciences research. Revvity serves a wide array of sectors including biotechnology, pharmaceuticals, and clinical diagnostics, providing essential tools and data analytics that aid in disease discovery, drug development, and health monitoring. The company's expertise in deploying cutting-edge technologies further reinforces its position as a critical enabler of scientific research and innovation. With its global reach and commitment to enhancing healthcare delivery, Revvity Inc. plays a pivotal role in advancing the capabilities of medical and scientific communities worldwide, driving progress in critical areas such as personalized medicine and preventive healthcare.

CEODr. Prahlad R. Singh Ph.D.
SectorHealthcare
IndustryDiagnostics & Research
Employees11,000

Company Statistics

FY 2025

Profile

$11.80BMarket Cap
$2.86BRevenue
0.00Shares Out
11,000Employees

Margins

54.77%Gross
27.74%EBITDA
12.49%Operating
9.39%Pre-Tax
8.45%Net

Valuation

48.91P/E
1.63P/B
4.13EV/Sales
18.02EV/EBITDA
23.16P/FCF

Growth (CAGR)

-4.82%Rev 3Yr
1.41%Rev 5Yr
-21.69%Op Inc 3Yr
-16.28%Op Inc 5Yr
-24.89%Net Inc 3Yr
-19.82%Net Inc 5Yr

Returns

1.96%ROA
3.23%ROE
2.94%ROIC

Financial Health

$919.86MCash & Cash Equivalents
$4.00BNet Debt
67.83%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Revvity Inc. (ticker: RVTY) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 11,000 employees. Market cap is $11.8B.

The current price is $101.22 with a P/E ratio of 48.91x and P/B of 1.63x.

ROE is 3.23% and operating margin is 12.49%. Annual revenue is $2.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Revvity Inc. (RVTY) Stock Forecast 2026 $101.22 — Price, Financials & Analyst Targets | Alpha Lenz